Patent · US Active

Humanized Aβ antibodies for use in improving cognition

US8916165B2 · kind B2 · utility

10Cited by
191References
37Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 15, 2005
Grant dateDec 23, 2014
Priority date—
Expiry dateJun 15, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides improved agents and methods for treatment of diseases associated with beta amyloid (Aβ). Preferred agents include antibodies, e.g., humanized antibodies specific for Aβ.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.